Management of patients with magnetically controlled growth rods amidst the global COVID-19 pandemic.


Journal

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
ISSN: 1432-0932
Titre abrégé: Eur Spine J
Pays: Germany
ID NLM: 9301980

Informations de publication

Date de publication:
10 2020
Historique:
received: 22 04 2020
accepted: 18 06 2020
revised: 09 06 2020
pubmed: 1 7 2020
medline: 8 10 2020
entrez: 1 7 2020
Statut: ppublish

Résumé

At the time of writing, we are all coping with the global COVID-19 pandemic. Amongst other things, this has had a significant impact on postponing virtually all routine clinic visits and elective surgeries. Concurrently, the Magnetic Expansion Control (MAGEC) rod has been issued with a number of field safety notices and UK regulator medical device alerts. This document serves to provide an overview of the current situation regarding the use of MAGEC rods, primarily in the UK, and the impact that the pandemic has had on the management of patients with these rods. The care of each patient must of course be determined on an individual basis; however, the experience of the authors is that a short delay in scheduled distractions and clinic visits will not adversely impact patient treatment. The authors caution against a gap in distractions of longer than 6 months and emphasise the importance of continued remote patient monitoring to identify those who may need to be seen more urgently.

Identifiants

pubmed: 32601848
doi: 10.1007/s00586-020-06516-2
pii: 10.1007/s00586-020-06516-2
pmc: PMC7324002
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2409-2412

Références

Eur Spine J. 2017 Jun;26(6):1699-1710
pubmed: 28102447
J Trace Elem Med Biol. 2020 Jan;57:9-17
pubmed: 31546210

Auteurs

Harry Hothi (H)

The Royal National Orthopaedic Hospital and Institute of Orthopaedics and Musculoskeletal Science, University College London, Brockley Hill, Stanmore, HA74LP, UK. h.hothi@ucl.ac.uk.

Stewart Tucker (S)

Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK.

Masood Shafafy (M)

Department of Trauma and Orthopaedics, Nottingham University Hospitals NHS Trust, Nottingham, UK.

Colin Nnadi (C)

Nuffield Orthopaedic Centre, Oxford University Hospital, Headington, Oxford, UK.

Kenneth M C Cheung (KMC)

Department of Orthopaedics and Traumatology, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong SAR, China.

Elisabetta Dal Gal (E)

The Royal National Orthopaedic Hospital and Institute of Orthopaedics and Musculoskeletal Science, University College London, Brockley Hill, Stanmore, HA74LP, UK.

Martina Tognini (M)

The Royal National Orthopaedic Hospital and Institute of Orthopaedics and Musculoskeletal Science, University College London, Brockley Hill, Stanmore, HA74LP, UK.

Johann Henckel (J)

The Royal National Orthopaedic Hospital and Institute of Orthopaedics and Musculoskeletal Science, University College London, Brockley Hill, Stanmore, HA74LP, UK.

John Skinner (J)

The Royal National Orthopaedic Hospital and Institute of Orthopaedics and Musculoskeletal Science, University College London, Brockley Hill, Stanmore, HA74LP, UK.

Alister Hart (A)

The Royal National Orthopaedic Hospital and Institute of Orthopaedics and Musculoskeletal Science, University College London, Brockley Hill, Stanmore, HA74LP, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH